The DES (diethylstilbestrol) years

Bridging the past into the future

Martin A. Martino, Nicole S. Nevadunsky, Thomas J. Magliaro, Michael I. Goldberg

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Between the years 1941-1971, it is estimated that between 5 million and 10 million pregnancies were exposed to diethylstilbestrol (DES). The adverse consequences of this exposure in utero had been reported as early as 1949. However, it was not until the development of a rare vaginal cancer known as clear-cell adenocarcinoma in 1971 that the implications with regard to teratogenicity of this steroid were identified. The use of anecdotal reports to develop preventive treatments cautions physicians regarding the consequences that may result when anecdotal reports are relied on to determine medical management rather than evidence-based research. This article will review the history and pathology of DES and alert the primary care physician to the misfortunes of our past and the implications they may have in the future. With the increased prevalence of alternative treatments and homeopathic remedies, the contemporary physician must be mindful of the importance of evidence-based medicine when prescribing therapeutics. Finally, this article will discuss the importance of evidence-based medicine and remind us to learn from our past experiences when we introduce new treatments in the future.

Original languageEnglish (US)
Pages (from-to)7-12
Number of pages6
JournalPrimary Care Update for Ob/Gyns
Volume9
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Diethylstilbestrol
Evidence-Based Medicine
Vaginal Neoplasms
Clear Cell Adenocarcinoma
Materia Medica
Physicians
Primary Care Physicians
Therapeutics
History
Steroids
Pathology
Pregnancy
Research

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Nursing(all)

Cite this

The DES (diethylstilbestrol) years : Bridging the past into the future. / Martino, Martin A.; Nevadunsky, Nicole S.; Magliaro, Thomas J.; Goldberg, Michael I.

In: Primary Care Update for Ob/Gyns, Vol. 9, No. 1, 2002, p. 7-12.

Research output: Contribution to journalArticle

Martino, Martin A. ; Nevadunsky, Nicole S. ; Magliaro, Thomas J. ; Goldberg, Michael I. / The DES (diethylstilbestrol) years : Bridging the past into the future. In: Primary Care Update for Ob/Gyns. 2002 ; Vol. 9, No. 1. pp. 7-12.
@article{8b5d570e139e42ff8b941c2b38764910,
title = "The DES (diethylstilbestrol) years: Bridging the past into the future",
abstract = "Between the years 1941-1971, it is estimated that between 5 million and 10 million pregnancies were exposed to diethylstilbestrol (DES). The adverse consequences of this exposure in utero had been reported as early as 1949. However, it was not until the development of a rare vaginal cancer known as clear-cell adenocarcinoma in 1971 that the implications with regard to teratogenicity of this steroid were identified. The use of anecdotal reports to develop preventive treatments cautions physicians regarding the consequences that may result when anecdotal reports are relied on to determine medical management rather than evidence-based research. This article will review the history and pathology of DES and alert the primary care physician to the misfortunes of our past and the implications they may have in the future. With the increased prevalence of alternative treatments and homeopathic remedies, the contemporary physician must be mindful of the importance of evidence-based medicine when prescribing therapeutics. Finally, this article will discuss the importance of evidence-based medicine and remind us to learn from our past experiences when we introduce new treatments in the future.",
author = "Martino, {Martin A.} and Nevadunsky, {Nicole S.} and Magliaro, {Thomas J.} and Goldberg, {Michael I.}",
year = "2002",
doi = "10.1016/S1068-607X(01)00095-6",
language = "English (US)",
volume = "9",
pages = "7--12",
journal = "Primary Care Update for Ob/Gyns",
issn = "1068-607X",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - The DES (diethylstilbestrol) years

T2 - Bridging the past into the future

AU - Martino, Martin A.

AU - Nevadunsky, Nicole S.

AU - Magliaro, Thomas J.

AU - Goldberg, Michael I.

PY - 2002

Y1 - 2002

N2 - Between the years 1941-1971, it is estimated that between 5 million and 10 million pregnancies were exposed to diethylstilbestrol (DES). The adverse consequences of this exposure in utero had been reported as early as 1949. However, it was not until the development of a rare vaginal cancer known as clear-cell adenocarcinoma in 1971 that the implications with regard to teratogenicity of this steroid were identified. The use of anecdotal reports to develop preventive treatments cautions physicians regarding the consequences that may result when anecdotal reports are relied on to determine medical management rather than evidence-based research. This article will review the history and pathology of DES and alert the primary care physician to the misfortunes of our past and the implications they may have in the future. With the increased prevalence of alternative treatments and homeopathic remedies, the contemporary physician must be mindful of the importance of evidence-based medicine when prescribing therapeutics. Finally, this article will discuss the importance of evidence-based medicine and remind us to learn from our past experiences when we introduce new treatments in the future.

AB - Between the years 1941-1971, it is estimated that between 5 million and 10 million pregnancies were exposed to diethylstilbestrol (DES). The adverse consequences of this exposure in utero had been reported as early as 1949. However, it was not until the development of a rare vaginal cancer known as clear-cell adenocarcinoma in 1971 that the implications with regard to teratogenicity of this steroid were identified. The use of anecdotal reports to develop preventive treatments cautions physicians regarding the consequences that may result when anecdotal reports are relied on to determine medical management rather than evidence-based research. This article will review the history and pathology of DES and alert the primary care physician to the misfortunes of our past and the implications they may have in the future. With the increased prevalence of alternative treatments and homeopathic remedies, the contemporary physician must be mindful of the importance of evidence-based medicine when prescribing therapeutics. Finally, this article will discuss the importance of evidence-based medicine and remind us to learn from our past experiences when we introduce new treatments in the future.

UR - http://www.scopus.com/inward/record.url?scp=0036169989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036169989&partnerID=8YFLogxK

U2 - 10.1016/S1068-607X(01)00095-6

DO - 10.1016/S1068-607X(01)00095-6

M3 - Article

VL - 9

SP - 7

EP - 12

JO - Primary Care Update for Ob/Gyns

JF - Primary Care Update for Ob/Gyns

SN - 1068-607X

IS - 1

ER -